Walleye Trading
FATE icon

Walleye Trading’s Fate Therapeutics FATE Stock Holding History

Walleye Trading’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,735
Closed -$118K – 4988
2022
Q4 		$118K Buy
+11,735
New +$220K ﹤0.01% 3887
2021
Q1 		– Sell
-2,740
Closed -$249K – 4940
2020
Q4 		$249K Buy
+2,740
New +$170K ﹤0.01% 3326
2016
Q3 		– Sell
-1,100
Closed -$2K – 5003
2016
Q2 		$2K Sell
1,100
-200
-15% -$363 ﹤0.01% 5110
2016
Q1 		$2K Sell
1,300
-9,000
-87% -$18.5K ﹤0.01% 5107
2015
Q4 		$35K Buy
10,300
+5,000
+94% +$21K ﹤0.01% 4092
2015
Q3 		$28K Buy
5,300
+4,600
+657% +$31.4K ﹤0.01% 3881
2015
Q2 		$5K Buy
+700
New +$4.19K ﹤0.01% 4495

Other funds holding FATE

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Walleye Trading's FATE Position: Q1 2023 in Review

Walleye Trading sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 11,735 shares — an estimated $118K sold.

Walleye Trading first reported a position in FATE in Q2 2015 and held it in 7 quarters. The position peaked at $249K in Q4 2020. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • Walleye Trading reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 11,735 Fate Therapeutics shares in Q1 2023, an estimated $118K.
  • Walleye Trading first reported a position in Fate Therapeutics in Q2 2015 and held it in 7 quarters.
  • Walleye Trading's Fate Therapeutics position peaked at $249K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.